The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...

As genomic technologies become more accessible, they have the potential to reduce healthcare disparities and improve equity ...

Recent research found a correlation between the upfront time to build and release a clinical database and its impact on downstream data management processes in conducting and completing trials.

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, CEO, CluePoints, discusses goals of the SCOPE Summit and CluePoints' evolving approach to risk detection.

In this modern era, where artificial intelligence is reshaping industries, healthcare is witnessing a profound transformation ...

As we reflect on the past two years of integrating generative AI into product management, it becomes evident that the challenges and opportunities it presents echo those experienced during Agile ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

We show that our assumption is supported by data on test score dynamics for older workers in the HRS. Using survey data from the PSID and administrative data from the IRS and SSA, we estimate that the ...